Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2

Reporting results of cancer treatment

1981 • 7,916 citations

Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer

1991 • 2,563 citations

Manual for Staging of Cancer

1992 • 2,367 citations

Head and Neck Cancer

1993 • 2,263 citations

Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo

1994 • 416 citations

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.

1996 • 385 citations

Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology group

1988 • 262 citations

Overview of Combined Modality Therapies for Head and Neck Cancer

1993 • 214 citations

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin-2 injected periiymphatically

1988 • 151 citations

Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.

1990 • 144 citations

Favorable Long-Term Survival Following Induction Chemotherapy With Cisplatin, Fluorouracil, and Leucovorin and Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Cancer

1992 • 95 citations

Chemotherapy for squamous cell carcinoma of head and neck: The future is now

1996 • 87 citations

Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.

1988 • 75 citations

Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.

1993 • 71 citations

Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer

1991 • 58 citations

Induction of tumor regression in experimental model of human head and neck cancer by human a‐lak cells and IL‐2

1991 • 48 citations

Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group Trial

1994 • 40 citations

Local Adoptive Immunotherapy of Advanced Head and Neck Tumors with Lak Cells and Interleukin-2

1990 • 35 citations

Interleukin-2, Cisplatin, and 5-Fluorouracil for Patients with Non-Small Cell Lung and Head/Neck Carcinomas

1991 • 30 citations

Adoptive Immunotherapy for Head and Neck Cancer with Killer Cells Induced by Stimulation with Autologous or Allogeneic Tumour Cells and Recombinant Interleukin-2

1989 • 28 citations

A phase II study of interleukin-2 and interferon-alpha in head and neck cancer

1992 • 21 citations

Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.

1990 • 20 citations

Phase II Study of High-Dose Ifosfamide as a Single Agent and in Combination with Cisplatin in the Treatment of Advanced and/or Recurrent Squamous Cell Carcinoma of Head and Neck

1993 • 17 citations

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck

1997 • 17 citations

Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck

1989 • 15 citations

New drug therapy for squamous carcinoma of the head and neck

1996 • 11 citations

Induction of lymphokine-activated killer cells with low-dose interleukin 2 and interferon-? in oral cancer patients

1992 • 8 citations

[Neo-adjuvant chemotherapy in patients with head and neck cancer].

1995 • 2 citations